nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Bexarotene—hematologic cancer	0.0901	0.191	CbGbCtD
Glimepiride—CYP2C9—Idarubicin—hematologic cancer	0.0747	0.159	CbGbCtD
Glimepiride—CYP2C9—Bortezomib—hematologic cancer	0.0553	0.117	CbGbCtD
Glimepiride—CYP2C9—Thalidomide—hematologic cancer	0.0481	0.102	CbGbCtD
Glimepiride—CYP2C9—Teniposide—hematologic cancer	0.0459	0.0975	CbGbCtD
Glimepiride—CYP2C9—Ifosfamide—hematologic cancer	0.0424	0.09	CbGbCtD
Glimepiride—CYP2C9—Imatinib—hematologic cancer	0.0405	0.0859	CbGbCtD
Glimepiride—CYP2C9—Nilotinib—hematologic cancer	0.0368	0.0781	CbGbCtD
Glimepiride—CYP2C9—Cisplatin—hematologic cancer	0.0206	0.0438	CbGbCtD
Glimepiride—CYP2C9—Dexamethasone—hematologic cancer	0.0167	0.0354	CbGbCtD
Glimepiride—Gliclazide—VEGFA—hematologic cancer	0.00181	0.366	CrCbGaD
Glimepiride—Glyburide—ABCC3—hematologic cancer	0.00121	0.244	CrCbGaD
Glimepiride—Glyburide—ABCG2—hematologic cancer	0.000586	0.118	CrCbGaD
Glimepiride—Gliclazide—ALB—hematologic cancer	0.000486	0.0983	CrCbGaD
Glimepiride—Chlorpropamide—ABCB1—hematologic cancer	0.000361	0.0729	CrCbGaD
Glimepiride—Glyburide—ALB—hematologic cancer	0.000256	0.0516	CrCbGaD
Glimepiride—Glyburide—ABCB1—hematologic cancer	0.000244	0.0493	CrCbGaD
Glimepiride—Loss of consciousness—Prednisone—hematologic cancer	8.95e-05	0.000173	CcSEcCtD
Glimepiride—Hypotension—Dexamethasone—hematologic cancer	8.92e-05	0.000172	CcSEcCtD
Glimepiride—Hypotension—Betamethasone—hematologic cancer	8.92e-05	0.000172	CcSEcCtD
Glimepiride—Nausea—Carmustine—hematologic cancer	8.91e-05	0.000172	CcSEcCtD
Glimepiride—Vomiting—Irinotecan—hematologic cancer	8.86e-05	0.000171	CcSEcCtD
Glimepiride—Vomiting—Mitoxantrone—hematologic cancer	8.86e-05	0.000171	CcSEcCtD
Glimepiride—Nausea—Alitretinoin—hematologic cancer	8.82e-05	0.00017	CcSEcCtD
Glimepiride—Convulsion—Prednisone—hematologic cancer	8.82e-05	0.00017	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—hematologic cancer	8.82e-05	0.00017	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—hematologic cancer	8.8e-05	0.00017	CcSEcCtD
Glimepiride—Hypertension—Prednisone—hematologic cancer	8.79e-05	0.00017	CcSEcCtD
Glimepiride—Rash—Irinotecan—hematologic cancer	8.79e-05	0.00017	CcSEcCtD
Glimepiride—Rash—Mitoxantrone—hematologic cancer	8.79e-05	0.00017	CcSEcCtD
Glimepiride—Dermatitis—Irinotecan—hematologic cancer	8.78e-05	0.00017	CcSEcCtD
Glimepiride—Dermatitis—Mitoxantrone—hematologic cancer	8.78e-05	0.00017	CcSEcCtD
Glimepiride—Headache—Irinotecan—hematologic cancer	8.73e-05	0.000169	CcSEcCtD
Glimepiride—Headache—Mitoxantrone—hematologic cancer	8.73e-05	0.000169	CcSEcCtD
Glimepiride—Nausea—Ifosfamide—hematologic cancer	8.72e-05	0.000168	CcSEcCtD
Glimepiride—Feeling abnormal—Triamcinolone—hematologic cancer	8.67e-05	0.000167	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—hematologic cancer	8.66e-05	0.000167	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—hematologic cancer	8.65e-05	0.000167	CcSEcCtD
Glimepiride—Anxiety—Prednisone—hematologic cancer	8.64e-05	0.000167	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—hematologic cancer	8.63e-05	0.000167	CcSEcCtD
Glimepiride—Insomnia—Dexamethasone—hematologic cancer	8.63e-05	0.000167	CcSEcCtD
Glimepiride—Insomnia—Betamethasone—hematologic cancer	8.63e-05	0.000167	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—hematologic cancer	8.62e-05	0.000166	CcSEcCtD
Glimepiride—Paraesthesia—Betamethasone—hematologic cancer	8.57e-05	0.000166	CcSEcCtD
Glimepiride—Paraesthesia—Dexamethasone—hematologic cancer	8.57e-05	0.000166	CcSEcCtD
Glimepiride—Rash—Gemcitabine—hematologic cancer	8.56e-05	0.000165	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—hematologic cancer	8.56e-05	0.000165	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—hematologic cancer	8.54e-05	0.000165	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—hematologic cancer	8.51e-05	0.000164	CcSEcCtD
Glimepiride—Erythema—Methotrexate—hematologic cancer	8.51e-05	0.000164	CcSEcCtD
Glimepiride—Headache—Gemcitabine—hematologic cancer	8.51e-05	0.000164	CcSEcCtD
Glimepiride—Nausea—Vincristine—hematologic cancer	8.5e-05	0.000164	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—hematologic cancer	8.47e-05	0.000164	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisolone—hematologic cancer	8.43e-05	0.000163	CcSEcCtD
Glimepiride—Dyspepsia—Dexamethasone—hematologic cancer	8.4e-05	0.000162	CcSEcCtD
Glimepiride—Dyspepsia—Betamethasone—hematologic cancer	8.4e-05	0.000162	CcSEcCtD
Glimepiride—Urticaria—Triamcinolone—hematologic cancer	8.36e-05	0.000161	CcSEcCtD
Glimepiride—Asthenia—Etoposide—hematologic cancer	8.32e-05	0.000161	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—hematologic cancer	8.31e-05	0.000161	CcSEcCtD
Glimepiride—Decreased appetite—Betamethasone—hematologic cancer	8.3e-05	0.00016	CcSEcCtD
Glimepiride—Decreased appetite—Dexamethasone—hematologic cancer	8.3e-05	0.00016	CcSEcCtD
Glimepiride—Nausea—Irinotecan—hematologic cancer	8.28e-05	0.00016	CcSEcCtD
Glimepiride—Nausea—Mitoxantrone—hematologic cancer	8.28e-05	0.00016	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.24e-05	0.000159	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.24e-05	0.000159	CcSEcCtD
Glimepiride—Fatigue—Betamethasone—hematologic cancer	8.23e-05	0.000159	CcSEcCtD
Glimepiride—Fatigue—Dexamethasone—hematologic cancer	8.23e-05	0.000159	CcSEcCtD
Glimepiride—Pruritus—Etoposide—hematologic cancer	8.2e-05	0.000158	CcSEcCtD
Glimepiride—Shock—Prednisone—hematologic cancer	8.18e-05	0.000158	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—hematologic cancer	8.17e-05	0.000158	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—hematologic cancer	8.16e-05	0.000158	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—hematologic cancer	8.11e-05	0.000157	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—hematologic cancer	8.07e-05	0.000156	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—hematologic cancer	8.05e-05	0.000155	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—hematologic cancer	8.04e-05	0.000155	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—hematologic cancer	8.02e-05	0.000155	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—hematologic cancer	8e-05	0.000155	CcSEcCtD
Glimepiride—Rash—Cisplatin—hematologic cancer	7.98e-05	0.000154	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—hematologic cancer	7.97e-05	0.000154	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—hematologic cancer	7.97e-05	0.000154	CcSEcCtD
Glimepiride—Erythema—Epirubicin—hematologic cancer	7.97e-05	0.000154	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—hematologic cancer	7.93e-05	0.000153	CcSEcCtD
Glimepiride—Anorexia—Prednisone—hematologic cancer	7.92e-05	0.000153	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—hematologic cancer	7.87e-05	0.000152	CcSEcCtD
Glimepiride—Feeling abnormal—Betamethasone—hematologic cancer	7.86e-05	0.000152	CcSEcCtD
Glimepiride—Feeling abnormal—Dexamethasone—hematologic cancer	7.86e-05	0.000152	CcSEcCtD
Glimepiride—Tension—Epirubicin—hematologic cancer	7.82e-05	0.000151	CcSEcCtD
Glimepiride—Gastrointestinal pain—Betamethasone—hematologic cancer	7.8e-05	0.000151	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.8e-05	0.000151	CcSEcCtD
Glimepiride—Hypersensitivity—Triamcinolone—hematologic cancer	7.75e-05	0.00015	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—hematologic cancer	7.74e-05	0.000149	CcSEcCtD
Glimepiride—Dizziness—Etoposide—hematologic cancer	7.67e-05	0.000148	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—hematologic cancer	7.62e-05	0.000147	CcSEcCtD
Glimepiride—Urticaria—Betamethasone—hematologic cancer	7.58e-05	0.000146	CcSEcCtD
Glimepiride—Urticaria—Dexamethasone—hematologic cancer	7.58e-05	0.000146	CcSEcCtD
Glimepiride—Dizziness—Prednisolone—hematologic cancer	7.56e-05	0.000146	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—hematologic cancer	7.56e-05	0.000146	CcSEcCtD
Glimepiride—Asthenia—Triamcinolone—hematologic cancer	7.55e-05	0.000146	CcSEcCtD
Glimepiride—Abdominal pain—Betamethasone—hematologic cancer	7.54e-05	0.000146	CcSEcCtD
Glimepiride—Abdominal pain—Dexamethasone—hematologic cancer	7.54e-05	0.000146	CcSEcCtD
Glimepiride—Nausea—Cisplatin—hematologic cancer	7.52e-05	0.000145	CcSEcCtD
Glimepiride—Insomnia—Prednisone—hematologic cancer	7.52e-05	0.000145	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—hematologic cancer	7.51e-05	0.000145	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—hematologic cancer	7.46e-05	0.000144	CcSEcCtD
Glimepiride—Pruritus—Triamcinolone—hematologic cancer	7.44e-05	0.000144	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—hematologic cancer	7.37e-05	0.000142	CcSEcCtD
Glimepiride—Vomiting—Etoposide—hematologic cancer	7.37e-05	0.000142	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—hematologic cancer	7.37e-05	0.000142	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—hematologic cancer	7.37e-05	0.000142	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—hematologic cancer	7.36e-05	0.000142	CcSEcCtD
Glimepiride—Agitation—Epirubicin—hematologic cancer	7.32e-05	0.000141	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—hematologic cancer	7.32e-05	0.000141	CcSEcCtD
Glimepiride—Rash—Etoposide—hematologic cancer	7.31e-05	0.000141	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—hematologic cancer	7.31e-05	0.000141	CcSEcCtD
Glimepiride—Headache—Etoposide—hematologic cancer	7.27e-05	0.00014	CcSEcCtD
Glimepiride—Tension—Doxorubicin—hematologic cancer	7.23e-05	0.00014	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—hematologic cancer	7.23e-05	0.00014	CcSEcCtD
Glimepiride—Rash—Prednisolone—hematologic cancer	7.21e-05	0.000139	CcSEcCtD
Glimepiride—Dermatitis—Prednisolone—hematologic cancer	7.21e-05	0.000139	CcSEcCtD
Glimepiride—Fatigue—Prednisone—hematologic cancer	7.17e-05	0.000138	CcSEcCtD
Glimepiride—Headache—Prednisolone—hematologic cancer	7.17e-05	0.000138	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—hematologic cancer	7.16e-05	0.000138	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—hematologic cancer	7.13e-05	0.000138	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—hematologic cancer	7.04e-05	0.000136	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—hematologic cancer	7e-05	0.000135	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—hematologic cancer	7e-05	0.000135	CcSEcCtD
Glimepiride—Dizziness—Triamcinolone—hematologic cancer	6.96e-05	0.000134	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—hematologic cancer	6.95e-05	0.000134	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—hematologic cancer	6.95e-05	0.000134	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—hematologic cancer	6.9e-05	0.000133	CcSEcCtD
Glimepiride—Nausea—Etoposide—hematologic cancer	6.89e-05	0.000133	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—hematologic cancer	6.88e-05	0.000133	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisone—hematologic cancer	6.85e-05	0.000132	CcSEcCtD
Glimepiride—Asthenia—Dexamethasone—hematologic cancer	6.85e-05	0.000132	CcSEcCtD
Glimepiride—Asthenia—Betamethasone—hematologic cancer	6.85e-05	0.000132	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—hematologic cancer	6.81e-05	0.000132	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—hematologic cancer	6.8e-05	0.000131	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—hematologic cancer	6.8e-05	0.000131	CcSEcCtD
Glimepiride—Nausea—Prednisolone—hematologic cancer	6.79e-05	0.000131	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—hematologic cancer	6.77e-05	0.000131	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—hematologic cancer	6.76e-05	0.000131	CcSEcCtD
Glimepiride—Pruritus—Dexamethasone—hematologic cancer	6.75e-05	0.00013	CcSEcCtD
Glimepiride—Pruritus—Betamethasone—hematologic cancer	6.75e-05	0.00013	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—hematologic cancer	6.72e-05	0.00013	CcSEcCtD
Glimepiride—Vomiting—Triamcinolone—hematologic cancer	6.69e-05	0.000129	CcSEcCtD
Glimepiride—Rash—Triamcinolone—hematologic cancer	6.63e-05	0.000128	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—hematologic cancer	6.63e-05	0.000128	CcSEcCtD
Glimepiride—Dermatitis—Triamcinolone—hematologic cancer	6.63e-05	0.000128	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—hematologic cancer	6.62e-05	0.000128	CcSEcCtD
Glimepiride—Urticaria—Prednisone—hematologic cancer	6.6e-05	0.000128	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—hematologic cancer	6.6e-05	0.000127	CcSEcCtD
Glimepiride—Headache—Triamcinolone—hematologic cancer	6.59e-05	0.000127	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—hematologic cancer	6.57e-05	0.000127	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—hematologic cancer	6.55e-05	0.000127	CcSEcCtD
Glimepiride—Diarrhoea—Betamethasone—hematologic cancer	6.53e-05	0.000126	CcSEcCtD
Glimepiride—Diarrhoea—Dexamethasone—hematologic cancer	6.53e-05	0.000126	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—hematologic cancer	6.51e-05	0.000126	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—hematologic cancer	6.5e-05	0.000126	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—hematologic cancer	6.49e-05	0.000125	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—hematologic cancer	6.48e-05	0.000125	CcSEcCtD
Glimepiride—Shock—Epirubicin—hematologic cancer	6.4e-05	0.000124	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—hematologic cancer	6.39e-05	0.000123	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—hematologic cancer	6.36e-05	0.000123	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—hematologic cancer	6.36e-05	0.000123	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—hematologic cancer	6.34e-05	0.000123	CcSEcCtD
Glimepiride—Dizziness—Dexamethasone—hematologic cancer	6.31e-05	0.000122	CcSEcCtD
Glimepiride—Dizziness—Betamethasone—hematologic cancer	6.31e-05	0.000122	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—hematologic cancer	6.28e-05	0.000121	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—hematologic cancer	6.28e-05	0.000121	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—hematologic cancer	6.25e-05	0.000121	CcSEcCtD
Glimepiride—Nausea—Triamcinolone—hematologic cancer	6.25e-05	0.000121	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—hematologic cancer	6.24e-05	0.00012	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—hematologic cancer	6.2e-05	0.00012	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—hematologic cancer	6.19e-05	0.00012	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—hematologic cancer	6.18e-05	0.000119	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—hematologic cancer	6.14e-05	0.000119	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisone—hematologic cancer	6.12e-05	0.000118	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—hematologic cancer	6.11e-05	0.000118	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—hematologic cancer	6.07e-05	0.000117	CcSEcCtD
Glimepiride—Vomiting—Betamethasone—hematologic cancer	6.07e-05	0.000117	CcSEcCtD
Glimepiride—Vomiting—Dexamethasone—hematologic cancer	6.07e-05	0.000117	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—hematologic cancer	6.06e-05	0.000117	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—hematologic cancer	6.04e-05	0.000117	CcSEcCtD
Glimepiride—Rash—Betamethasone—hematologic cancer	6.02e-05	0.000116	CcSEcCtD
Glimepiride—Rash—Dexamethasone—hematologic cancer	6.02e-05	0.000116	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—hematologic cancer	6.01e-05	0.000116	CcSEcCtD
Glimepiride—Dermatitis—Dexamethasone—hematologic cancer	6.01e-05	0.000116	CcSEcCtD
Glimepiride—Dermatitis—Betamethasone—hematologic cancer	6.01e-05	0.000116	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—hematologic cancer	6e-05	0.000116	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—hematologic cancer	5.99e-05	0.000116	CcSEcCtD
Glimepiride—Headache—Betamethasone—hematologic cancer	5.98e-05	0.000115	CcSEcCtD
Glimepiride—Headache—Dexamethasone—hematologic cancer	5.98e-05	0.000115	CcSEcCtD
Glimepiride—Asthenia—Prednisone—hematologic cancer	5.96e-05	0.000115	CcSEcCtD
Glimepiride—Shock—Doxorubicin—hematologic cancer	5.92e-05	0.000114	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—hematologic cancer	5.89e-05	0.000114	CcSEcCtD
Glimepiride—Pruritus—Prednisone—hematologic cancer	5.88e-05	0.000114	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—hematologic cancer	5.88e-05	0.000114	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—hematologic cancer	5.87e-05	0.000113	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—hematologic cancer	5.84e-05	0.000113	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—hematologic cancer	5.81e-05	0.000112	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—hematologic cancer	5.8e-05	0.000112	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—hematologic cancer	5.78e-05	0.000112	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—hematologic cancer	5.73e-05	0.000111	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—hematologic cancer	5.72e-05	0.000111	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—hematologic cancer	5.72e-05	0.000111	CcSEcCtD
Glimepiride—Diarrhoea—Prednisone—hematologic cancer	5.69e-05	0.00011	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—hematologic cancer	5.68e-05	0.00011	CcSEcCtD
Glimepiride—Nausea—Dexamethasone—hematologic cancer	5.67e-05	0.000109	CcSEcCtD
Glimepiride—Nausea—Betamethasone—hematologic cancer	5.67e-05	0.000109	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—hematologic cancer	5.65e-05	0.000109	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—hematologic cancer	5.62e-05	0.000109	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.61e-05	0.000108	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—hematologic cancer	5.6e-05	0.000108	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—hematologic cancer	5.52e-05	0.000107	CcSEcCtD
Glimepiride—Dizziness—Prednisone—hematologic cancer	5.5e-05	0.000106	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—hematologic cancer	5.49e-05	0.000106	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—hematologic cancer	5.44e-05	0.000105	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—hematologic cancer	5.4e-05	0.000104	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—hematologic cancer	5.36e-05	0.000104	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—hematologic cancer	5.36e-05	0.000103	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—hematologic cancer	5.35e-05	0.000103	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—hematologic cancer	5.32e-05	0.000103	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—hematologic cancer	5.29e-05	0.000102	CcSEcCtD
Glimepiride—Vomiting—Prednisone—hematologic cancer	5.28e-05	0.000102	CcSEcCtD
Glimepiride—Rash—Prednisone—hematologic cancer	5.24e-05	0.000101	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—hematologic cancer	5.24e-05	0.000101	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—hematologic cancer	5.23e-05	0.000101	CcSEcCtD
Glimepiride—Headache—Prednisone—hematologic cancer	5.21e-05	0.000101	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.19e-05	0.0001	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—hematologic cancer	5.19e-05	0.0001	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—hematologic cancer	5.16e-05	9.97e-05	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—hematologic cancer	5.14e-05	9.92e-05	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—hematologic cancer	5.12e-05	9.88e-05	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—hematologic cancer	4.98e-05	9.62e-05	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—hematologic cancer	4.96e-05	9.57e-05	CcSEcCtD
Glimepiride—Nausea—Prednisone—hematologic cancer	4.94e-05	9.53e-05	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.92e-05	9.5e-05	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—hematologic cancer	4.91e-05	9.49e-05	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—hematologic cancer	4.79e-05	9.25e-05	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—hematologic cancer	4.78e-05	9.23e-05	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—hematologic cancer	4.75e-05	9.18e-05	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—hematologic cancer	4.75e-05	9.18e-05	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—hematologic cancer	4.66e-05	9.01e-05	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—hematologic cancer	4.6e-05	8.88e-05	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—hematologic cancer	4.59e-05	8.87e-05	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—hematologic cancer	4.45e-05	8.59e-05	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—hematologic cancer	4.43e-05	8.56e-05	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—hematologic cancer	4.42e-05	8.53e-05	CcSEcCtD
Glimepiride—Rash—Methotrexate—hematologic cancer	4.38e-05	8.46e-05	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—hematologic cancer	4.38e-05	8.45e-05	CcSEcCtD
Glimepiride—Headache—Methotrexate—hematologic cancer	4.35e-05	8.4e-05	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—hematologic cancer	4.32e-05	8.33e-05	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—hematologic cancer	4.3e-05	8.3e-05	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—hematologic cancer	4.26e-05	8.22e-05	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—hematologic cancer	4.13e-05	7.98e-05	CcSEcCtD
Glimepiride—Nausea—Methotrexate—hematologic cancer	4.13e-05	7.97e-05	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—hematologic cancer	4.12e-05	7.95e-05	CcSEcCtD
Glimepiride—Rash—Epirubicin—hematologic cancer	4.1e-05	7.92e-05	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—hematologic cancer	4.09e-05	7.91e-05	CcSEcCtD
Glimepiride—Headache—Epirubicin—hematologic cancer	4.07e-05	7.86e-05	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—hematologic cancer	3.98e-05	7.68e-05	CcSEcCtD
Glimepiride—Nausea—Epirubicin—hematologic cancer	3.86e-05	7.46e-05	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—hematologic cancer	3.82e-05	7.39e-05	CcSEcCtD
Glimepiride—Rash—Doxorubicin—hematologic cancer	3.79e-05	7.32e-05	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—hematologic cancer	3.79e-05	7.32e-05	CcSEcCtD
Glimepiride—Headache—Doxorubicin—hematologic cancer	3.77e-05	7.28e-05	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—hematologic cancer	3.57e-05	6.9e-05	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—ADCY7—hematologic cancer	3.49e-05	0.00561	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.48e-05	0.00558	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—ADCY7—hematologic cancer	3.39e-05	0.00544	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.27e-05	0.00525	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	3.17e-05	0.00508	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CAMK2D—hematologic cancer	3.11e-05	0.00499	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.1e-05	0.00498	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	3.02e-05	0.00484	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CAMK2D—hematologic cancer	3.01e-05	0.00484	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	3e-05	0.00481	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—CREB1—hematologic cancer	2.85e-05	0.00457	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.84e-05	0.00455	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.84e-05	0.00455	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.84e-05	0.00455	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—BRAF—hematologic cancer	2.81e-05	0.00451	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.56e-05	0.0041	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.55e-05	0.0041	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GMPS—hematologic cancer	2.53e-05	0.00406	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FTCD—hematologic cancer	2.53e-05	0.00406	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PHYH—hematologic cancer	2.53e-05	0.00406	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—SLC35B2—hematologic cancer	2.51e-05	0.00404	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—EPHX1—hematologic cancer	2.48e-05	0.00398	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.48e-05	0.00398	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FTCD—hematologic cancer	2.45e-05	0.00393	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PHYH—hematologic cancer	2.45e-05	0.00393	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GMPS—hematologic cancer	2.45e-05	0.00393	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—MDM2—hematologic cancer	2.36e-05	0.00378	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SMPD3—hematologic cancer	2.31e-05	0.00371	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SMPD3—hematologic cancer	2.24e-05	0.0036	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.24e-05	0.0036	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.05e-05	0.00329	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ASNS—hematologic cancer	2.02e-05	0.00324	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—DCK—hematologic cancer	2.02e-05	0.00324	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—B3GAT1—hematologic cancer	2.02e-05	0.00324	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—PRKCG—hematologic cancer	1.97e-05	0.00315	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ASNS—hematologic cancer	1.96e-05	0.00315	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—B3GAT1—hematologic cancer	1.96e-05	0.00315	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—DCK—hematologic cancer	1.96e-05	0.00315	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.94e-05	0.00311	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HDC—hematologic cancer	1.92e-05	0.00308	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—PRKCG—hematologic cancer	1.91e-05	0.00306	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.88e-05	0.00301	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.87e-05	0.00299	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HDC—hematologic cancer	1.86e-05	0.00298	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.83e-05	0.00293	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CDA—hematologic cancer	1.75e-05	0.00281	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CDA—hematologic cancer	1.7e-05	0.00273	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PC—hematologic cancer	1.69e-05	0.00271	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PC—hematologic cancer	1.64e-05	0.00263	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC35B2—hematologic cancer	1.63e-05	0.00261	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GBA—hematologic cancer	1.63e-05	0.00261	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.63e-05	0.00261	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTO1—hematologic cancer	1.62e-05	0.0026	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTO1—hematologic cancer	1.6e-05	0.00256	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC35B2—hematologic cancer	1.58e-05	0.00254	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GBA—hematologic cancer	1.58e-05	0.00254	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—UGT1A1—hematologic cancer	1.52e-05	0.00244	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—UGT1A1—hematologic cancer	1.5e-05	0.00241	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	1.5e-05	0.0024	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTAP—hematologic cancer	1.49e-05	0.00239	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CREB1—hematologic cancer	1.46e-05	0.00234	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTAP—hematologic cancer	1.45e-05	0.00232	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BRAF—hematologic cancer	1.44e-05	0.00231	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CREB1—hematologic cancer	1.41e-05	0.00226	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BRAF—hematologic cancer	1.39e-05	0.00224	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	1.37e-05	0.0022	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.37e-05	0.00219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FHL2—hematologic cancer	1.33e-05	0.00213	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—MTR—hematologic cancer	1.32e-05	0.00212	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGRN—hematologic cancer	1.3e-05	0.00209	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—HRAS—hematologic cancer	1.29e-05	0.00208	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FHL2—hematologic cancer	1.29e-05	0.00207	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGRN—hematologic cancer	1.26e-05	0.00203	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTT1—hematologic cancer	1.26e-05	0.00202	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—IDH2—hematologic cancer	1.24e-05	0.00198	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMMR—hematologic cancer	1.24e-05	0.00198	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—MDM2—hematologic cancer	1.2e-05	0.00193	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMMR—hematologic cancer	1.2e-05	0.00192	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—IDH2—hematologic cancer	1.2e-05	0.00192	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—MDM2—hematologic cancer	1.17e-05	0.00187	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ARNTL—hematologic cancer	1.16e-05	0.00186	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.14e-05	0.00183	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CA9—hematologic cancer	1.13e-05	0.00181	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACP5—hematologic cancer	1.13e-05	0.00181	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ARNTL—hematologic cancer	1.13e-05	0.00181	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOR2—hematologic cancer	1.11e-05	0.00179	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACP5—hematologic cancer	1.1e-05	0.00176	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CA9—hematologic cancer	1.1e-05	0.00176	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOR2—hematologic cancer	1.08e-05	0.00173	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—IDH1—hematologic cancer	1.06e-05	0.0017	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCC3—hematologic cancer	1.05e-05	0.00168	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TXN—hematologic cancer	1.05e-05	0.00168	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTO1—hematologic cancer	1.05e-05	0.00168	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—IDH1—hematologic cancer	1.03e-05	0.00165	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SPHK1—hematologic cancer	1.03e-05	0.00165	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTO1—hematologic cancer	1.02e-05	0.00163	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCC3—hematologic cancer	1.02e-05	0.00163	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TXN—hematologic cancer	1.02e-05	0.00163	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SPHK1—hematologic cancer	9.97e-06	0.0016	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—UGT1A1—hematologic cancer	9.87e-06	0.00158	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	9.66e-06	0.00155	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC22A1—hematologic cancer	9.6e-06	0.00154	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CRABP1—hematologic cancer	9.6e-06	0.00154	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UGT1A1—hematologic cancer	9.57e-06	0.00154	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALOX5—hematologic cancer	9.36e-06	0.0015	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC22A1—hematologic cancer	9.31e-06	0.00149	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CRABP1—hematologic cancer	9.31e-06	0.00149	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALOX5—hematologic cancer	9.08e-06	0.00146	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NUP98—hematologic cancer	9.07e-06	0.00145	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADCY7—hematologic cancer	8.8e-06	0.00141	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA3—hematologic cancer	8.8e-06	0.00141	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NUP98—hematologic cancer	8.79e-06	0.00141	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NUP214—hematologic cancer	8.74e-06	0.0014	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	8.71e-06	0.0014	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	8.59e-06	0.00138	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTR—hematologic cancer	8.56e-06	0.00137	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG2—hematologic cancer	8.56e-06	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADCY7—hematologic cancer	8.53e-06	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA3—hematologic cancer	8.53e-06	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NUP214—hematologic cancer	8.47e-06	0.00136	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ENO2—hematologic cancer	8.4e-06	0.00135	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTR—hematologic cancer	8.3e-06	0.00133	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG2—hematologic cancer	8.3e-06	0.00133	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—hematologic cancer	8.14e-06	0.00131	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ENO2—hematologic cancer	8.14e-06	0.00131	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	8e-06	0.00128	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SDC1—hematologic cancer	7.96e-06	0.00128	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—hematologic cancer	7.9e-06	0.00127	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	7.89e-06	0.00127	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	7.87e-06	0.00126	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SDC1—hematologic cancer	7.72e-06	0.00124	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.62e-06	0.00122	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—hematologic cancer	7.14e-06	0.00114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	6.88e-06	0.0011	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NQO1—hematologic cancer	6.77e-06	0.00109	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD44—hematologic cancer	6.77e-06	0.00109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PHYH—hematologic cancer	6.67e-06	0.00107	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GMPS—hematologic cancer	6.67e-06	0.00107	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FTCD—hematologic cancer	6.67e-06	0.00107	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—HRAS—hematologic cancer	6.61e-06	0.00106	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	6.61e-06	0.00106	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NQO1—hematologic cancer	6.56e-06	0.00105	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD44—hematologic cancer	6.56e-06	0.00105	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—HRAS—hematologic cancer	6.41e-06	0.00103	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYCS—hematologic cancer	6.4e-06	0.00103	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSP90AA1—hematologic cancer	6.36e-06	0.00102	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	6.29e-06	0.00101	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	6.22e-06	0.000999	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYCS—hematologic cancer	6.21e-06	0.000996	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSP90AA1—hematologic cancer	6.17e-06	0.00099	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SMPD3—hematologic cancer	6.1e-06	0.000979	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	6.09e-06	0.000977	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	5.69e-06	0.000913	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—hematologic cancer	5.64e-06	0.000906	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	5.55e-06	0.00089	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—hematologic cancer	5.47e-06	0.000878	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—hematologic cancer	5.34e-06	0.000857	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—B3GAT1—hematologic cancer	5.34e-06	0.000856	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—DCK—hematologic cancer	5.34e-06	0.000856	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ASNS—hematologic cancer	5.34e-06	0.000856	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	5.22e-06	0.000837	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—hematologic cancer	5.19e-06	0.000832	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOR1—hematologic cancer	5.19e-06	0.000832	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—hematologic cancer	5.18e-06	0.000831	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HDC—hematologic cancer	5.06e-06	0.000812	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOR1—hematologic cancer	5.03e-06	0.000807	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—hematologic cancer	5.03e-06	0.000807	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.72e-06	0.000757	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CDA—hematologic cancer	4.63e-06	0.000742	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—hematologic cancer	4.58e-06	0.000735	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PC—hematologic cancer	4.45e-06	0.000715	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—hematologic cancer	4.44e-06	0.000713	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GBA—hematologic cancer	4.3e-06	0.00069	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC35B2—hematologic cancer	4.3e-06	0.00069	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTAP—hematologic cancer	3.93e-06	0.000631	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—hematologic cancer	3.85e-06	0.000618	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—hematologic cancer	3.73e-06	0.000599	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CREBBP—hematologic cancer	3.57e-06	0.000573	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FHL2—hematologic cancer	3.51e-06	0.000563	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CREBBP—hematologic cancer	3.46e-06	0.000556	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGRN—hematologic cancer	3.44e-06	0.000552	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CD—hematologic cancer	3.39e-06	0.000543	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—hematologic cancer	3.34e-06	0.000536	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CD—hematologic cancer	3.28e-06	0.000527	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—IDH2—hematologic cancer	3.26e-06	0.000523	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMMR—hematologic cancer	3.26e-06	0.000523	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—hematologic cancer	3.24e-06	0.00052	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3R1—hematologic cancer	3.2e-06	0.000513	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3R1—hematologic cancer	3.1e-06	0.000497	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.07e-06	0.000493	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ARNTL—hematologic cancer	3.06e-06	0.000492	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACP5—hematologic cancer	2.98e-06	0.000478	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA9—hematologic cancer	2.98e-06	0.000478	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CB—hematologic cancer	2.95e-06	0.000473	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOR2—hematologic cancer	2.94e-06	0.000472	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CB—hematologic cancer	2.86e-06	0.000459	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—IDH1—hematologic cancer	2.8e-06	0.00045	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTO1—hematologic cancer	2.77e-06	0.000445	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCC3—hematologic cancer	2.77e-06	0.000445	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TXN—hematologic cancer	2.77e-06	0.000445	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SPHK1—hematologic cancer	2.71e-06	0.000435	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UGT1A1—hematologic cancer	2.61e-06	0.000418	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—hematologic cancer	2.55e-06	0.000409	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CRABP1—hematologic cancer	2.53e-06	0.000407	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC22A1—hematologic cancer	2.53e-06	0.000407	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—hematologic cancer	2.47e-06	0.000397	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALOX5—hematologic cancer	2.47e-06	0.000396	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—EP300—hematologic cancer	2.43e-06	0.00039	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NUP98—hematologic cancer	2.39e-06	0.000384	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—EP300—hematologic cancer	2.36e-06	0.000378	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADCY7—hematologic cancer	2.32e-06	0.000373	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA3—hematologic cancer	2.32e-06	0.000373	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NUP214—hematologic cancer	2.31e-06	0.00037	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.28e-06	0.000366	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG2—hematologic cancer	2.26e-06	0.000363	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTR—hematologic cancer	2.26e-06	0.000363	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENO2—hematologic cancer	2.22e-06	0.000355	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—hematologic cancer	2.15e-06	0.000345	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.12e-06	0.00034	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SDC1—hematologic cancer	2.1e-06	0.000337	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.01e-06	0.000322	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.98e-06	0.000318	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.89e-06	0.000304	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—hematologic cancer	1.8e-06	0.000289	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD44—hematologic cancer	1.79e-06	0.000287	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NQO1—hematologic cancer	1.79e-06	0.000287	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.75e-06	0.000281	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—hematologic cancer	1.74e-06	0.00028	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYCS—hematologic cancer	1.69e-06	0.000271	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.68e-06	0.000269	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.51e-06	0.000242	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.49e-06	0.000239	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—hematologic cancer	1.47e-06	0.000236	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.44e-06	0.000231	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—hematologic cancer	1.43e-06	0.000229	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.41e-06	0.000226	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.37e-06	0.00022	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.37e-06	0.00022	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.21e-06	0.000194	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.07e-06	0.000171	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.02e-06	0.000163	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CREBBP—hematologic cancer	9.42e-07	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.94e-07	0.000143	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—hematologic cancer	8.82e-07	0.000142	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.44e-07	0.000135	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.79e-07	0.000125	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—hematologic cancer	6.73e-07	0.000108	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—EP300—hematologic cancer	6.42e-07	0.000103	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.75e-07	7.62e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—hematologic cancer	3.88e-07	6.22e-05	CbGpPWpGaD
